Trevi Therapeutics (TRVI) EPS (Basic) Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | -14.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.73% |
| Dec 31, 2025 | -81.71% |
| Sep 30, 2025 | 12.64% |
| Jun 30, 2025 | 13.69% |
| Mar 31, 2025 | 28.45% |
| Dec 31, 2024 | 22.90% |
| Sep 30, 2024 | 27.42% |
| Jun 30, 2024 | 37.44% |
| Mar 31, 2024 | 36.52% |
| Dec 31, 2023 | 46.07% |
| Sep 30, 2023 | 42.00% |
| Jun 30, 2023 | 44.52% |
| Mar 31, 2023 | 50.00% |
| Dec 31, 2022 | 62.52% |
| Sep 30, 2022 | 33.61% |
| Jun 30, 2022 | 39.43% |
| Mar 31, 2022 | 74.12% |
| Dec 31, 2021 | 75.72% |
| Sep 30, 2021 | 72.43% |
| Jun 30, 2021 | 66.99% |
| Mar 31, 2021 | 66.87% |